Louis C. Lucido is Director & 10% Owner at BioCorRx Inc. (BICX). They have made 15 open-market trades across 2 companies since 2013, most recently 2024-12-31.
CIK 0001539788
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
15 open-market purchases totalling $4.6M since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BICX | BUY | 2024-01-12 | 2024-01-17 | $0.70 | $2K | N/A | N/A | N/A |
| BICX | BUY | 2023-04-03 | 2023-04-05 | $1.75 | $300K | N/A | N/A | N/A |
| BICX | BUY | 2023-01-30 | 2023-01-31 | $1.39 | $554 | N/A | N/A | N/A |
| BICX | BUY | 2023-01-26 | 2023-01-27 | $1.29 | $645 | N/A | N/A | N/A |
| BICX | BUY | 2023-01-24 | 2023-01-25 | $1.20 | $240 | N/A | N/A | N/A |
| BICX | BUY | 2023-01-13 | 2023-01-17 | $1.13 | $5K | N/A | N/A | N/A |
| BICX | BUY | 2022-12-30 | 2023-01-04 | $1.09 | $3K | N/A | N/A | N/A |
| BICX | BUY | 2022-12-12 | 2022-12-15 | $0.83 | $4K | N/A | N/A | N/A |
| BICX | BUY | 2022-09-06 | 2022-10-11 | $1.97 | $3K | N/A | N/A | N/A |
| BICX | BUY | 2022-08-29 | 2022-08-31 | $2.11 | $8K | N/A | N/A | N/A |
| BICX | BUY | 2022-08-25 | 2022-08-29 | $2.15 | $2K | N/A | N/A | N/A |
| BICX | BUY | 2021-10-19 | 2021-10-25 | $3.20 | $5K | N/A | N/A | N/A |
| BICX | BUY | 2021-01-22 | 2021-03-02 | $2.00 | $1.1M | N/A | N/A | N/A |
| BICX | BUY | 2019-04-03 | 2019-04-04 | $15.00 | $3.0M | N/A | N/A | N/A |
| DSL | BUY | 2013-09-06 | 2013-09-06 | $20.50 | $150K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.